Healthcare Medical Devices Biotechnology

AI in Drug Discovery Market

Global Industry Analysis and Forecast 2023-2030

Pages : 120

Base Year : 2022

Release Year : May 2024

Format : Pdf Ppt Xls

Report ID: KR404

Author : Omkar R.

Base Year

2022

Forecast Year

2023-2030

Historical Years

2018-2021

Market Value (2022)

USD 4.07 Billion

Forecasted Value (2030)

USD 36.06 Billion

CAGR (2023 - 2030)

31.94%

Fastest Growing Region (2023 - 2030)

Asia Pacific

Largest Region

North America

By Component

Software, Services.

By Computational Method

Machine Learning, Deep Learning, Bioinformatics, Cheminformatics, Natural Language Processing.

By Therapeutic Area

Oncology, Infectious Diseases, Cardiology, Endocrinology, Neurology, Psychology, Other.

By End Users

Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs).


infographics Img
CHOOSE LICENCE TYPE
CUSTOMIZATION OFFERED
  • Check Icon Additional Company Profiles
  • Check Icon Additional Countries
  • Check Icon Cross Segment Analysis
  • Check Icon Regional Market Dynamics
  • Check Icon Country-Level Trend Analysis
  • Check Icon Competitive Landscape Customization
  • Check Icon Extended Forecast Years
  • Check Icon Historical Data Up to 5 Years
The global AI in drug discovery market is projected to reach USD 36.06 billion by 2030, growing at a CAGR of 31.94% from 2023 to 2030.
The global AI in drug discovery market was valued at USD 4.07 billion in 2022.
Rising demand for personalized medicine and increasing investment in AI-powered drug discovery are driving the pharmaceutical industry's transformation.
Top manufacturers of AI in drug discovery market are Bayer AG, Novartis International AG, Pfizer Inc., AstraZeneca PLC, GlaxoSmithKline PLC (GSK), Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Sanofi S.A., Merck & Co., Inc., and others.
Asia-Pacific is the fastest growing region with the CAGR of 41.59% in the forecasted period (2023-2030) with the market value forecasted to reach at USD 13.97 billion.
By component, software segment will hold the maximum share in the AI in drug discovery market with the revenue value of USD 21.36 billion in 2030.
-->
Get the latest!

Get actionable strategies to empower your business and market domination

  • Deliver Revenue Impact
  • Demand Supply Patterns
  • Market Estimation
  • Real-Time Insights
  • Market Intelligence
  • Lucrative Growth Opportunities
  • Micro & Macro Economic Factors
  • Futuristic Market Solutions
  • Revenue-Driven Results
  • Innovative Thought Leadership